NCT06239272 2026-04-21NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)St. Jude Children's Research HospitalPhase 1/2 Recruiting139 enrolled
NCT05813327 2026-04-20Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue SarcomaWashington University School of MedicinePhase 1 Active not recruiting6 enrolled
NCT02180867 2026-04-13Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryNational Cancer Institute (NCI)Phase 2/3 Active not recruiting140 enrolled 22 charts
NCT07243626 2026-04-08Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue SarcomaSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Recruiting15 enrolled